[Dopamine receptor agonists in treatment of outpatient patients with Parkinson's disease].
The paper summarized an experience of pronoran (piribedil) treatment of 516 patients with Parkinson's disease (primary parkinsonism) conducted in the district outpatient clinics of 7 Moscow administrative areas. In 84 cases, the medication was used as a monotherapy and in 432--in combination with levodopa-contained drug madopar. An improvement of patient's state, with reducing of bradikinesia, tremor and rigidity, was achieved in 73.0 +/- 20.4% of the patients. Combined therapy allowed decreasing of madopar dosage in 58.5 +/- 16.7% of the patients. Pronoran (piribedil) is well tolerated. The authors recommend it for the treatment of outpatients with Parkinson's disease.
A N
AN
Boĭko
T T
TT
Batysheva
E S
ES
Chikina
I Iu
IIu
Artemova
T V
TV
Vdovichenko
A M
AM
Ismailov
N A
NA
Obydenova
L N
LN
Osipenko
L D
LD
Rotor
Ia Ia
IaIa
Vinevitskiĭ
V A
VA
Nesterova
D000553:Ambulatory Care; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D018491:Dopamine Agonists